What is it?
Flaxseed is the seed from the plant Linum usitatissimum. The seed or the seed oil is used to make medicine. The information on this page concerns medicine made from the SEED only. There is a separate listing for flaxseed OIL.
People use flaxseed for many conditions related to the gastrointestinal (GI) tract, including ongoing constipation, colon damage due to overuse of laxatives, diarrhea, inflammation of the lining of the large intestine (diverticulitis), irritable bowel syndrome (IBS) or irritable colon, sores in the lining of the large intestine (ulcerative colitis), inflammation of the lining of the stomach (gastritis), and inflammation of the small intestine (enteritis).
Flaxseed is also used for disorders of the heart and blood vessels, including high cholesterol, “hardening of the arteries” (atherosclerosis), high blood pressure (hypertension), and coronary artery disease.
Flaxseed is also used for acne, attention deficit-hyperactivity disorder (ADHD), kidney problems in people with a disease called systemic lupus erythematosus (SLE), symptoms of menopause, and breast pain. It is also used for diabetes, obesity and weight loss, HIV/AIDS, depression, bladder infections, malaria, and rheumatoid arthritis.
Other uses include treatment of sore throat, upper respiratory tract infections (URTI), and cough.
Some people use flaxseed to lower their risk of getting weak bones (osteoporosis) and to protect against breast cancer, lung cancer, colon cancer, and prostate cancer.
Flaxseed is sometimes applied to the skin for acne, burns, boils, eczema, psoriasis, and to soothe inflammation.
How effective is it?
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, Ineffective, and Insufficient Evidence to Rate.
The effectiveness ratings for FLAXSEED are as follows:
Possibly effective for...
- Diabetes. Research shows that taking a specific flaxseed product (FlaxEssence, Jarrow Formulas) three times daily for 3 months lowers hemoglobin A1C, a measure of average blood sugar level, in people with type 2 diabetes. Other clinical research shows that taking flaxseed powder for one month can reduce fasting blood glucose in people with type 2 diabetes, and taking flaxseed for 3 months can reduce blood sugar levels in people with glucose-intolerance. However, taking milled flaxseed does not seem to lower fasting blood sugar, insulin levels, or blood fats in people with type 2 diabetes.
- High cholesterol. Research shows that various flaxseed preparations, including ground flaxseed, partially defatted flaxseed, and flaxseed bread and muffins, seem to reduce total cholesterol and the “bad cholesterol,” low-density lipoprotein (LDL) cholesterol, in people with normal cholesterol levels and in men and pre-menopausal women with high cholesterol. However, flaxseed does not have much effect on “good cholesterol,” high-density lipoprotein (HDL) cholesterol. Most flaxseed preparations do not affect triglyceride levels. However, partially defatted flaxseed (flaxseed without as much alpha-linolenic acid content) can increase triglycerides.
- Autoimmune disorder (systemic lupus erythematosus, SLE). Taking flaxseed by mouth seems to improve kidney function in people with SLE.
Possibly ineffective for...
- Osteoporosis. Research shows that consuming 40 grams of ground flaxseed daily for up to one year does not improve bone density in women. Similar findings were found for older men and women who took flaxseed extract.
Insufficient evidence to rate effectiveness for...
- Enlarged prostate (benign prostatic hyperplasia; BPH). Early research shows that taking a specific flaxseed product (Beneflax) daily for 4 months reduces urinary tract symptoms associated with BPH and improves quality of life.
- Breast cancer. Early research shows that eating a muffin containing 25 grams of flaxseed daily for about 40 days reduces tumor cell growth in women recently diagnosed with breast cancer. However, it is unclear if this effect significantly improves overall breast cancer outcomes. There is inconsistent evidence regarding the effects of dietary flaxseed on breast cancer development.
- Heart disease. Research suggests that dietary intake of lignans, which are found in flaxseed and other foods, does not reduce the risk of heart disease.
- Colorectal cancer. Research on the effect of flaxseed on colorectal cancer risk is inconsistent. Some research shows that consumption of lignans, which are in flaxseed, is not associated with a reduced risk of colorectal cancer. However, other research suggests that it is.
- Constipation. Flaxseed is a good source of dietary fiber. Eating flaxseed-containing muffins seems to increase bowel movements in young adults, while eating flaxseed-containing yogurt seems to increase bowel movements in elderly people.
- Endometrial cancer. Research suggests that blood levels of lignans, which are found in flaxseed and other foods, are not associated with endometrial cancer risk.
- High blood pressure. Early research shows that taking flaxseed extract three times daily for 6 months reduces blood pressure in men but not in women.
- Irritable bowel syndrome (IBS). Early research shows that taking 24 grams of flaxseed daily for 4 weeks does not improve quality of life or the severity of IBS symptoms in people with IBS.
- Lung cancer. Research suggests that people who eat more phytoestrogens, such as those found in flaxseed, might have a lower risk of developing lung cancer than those who eat less.
- Breast pain (mastalgia). In early research, eating a flaxseed muffin each day for 3 months reduced breast pain associated with the start of the menstrual cycle. The muffins each contained 25 grams of flaxseed.
- Menopausal symptoms. It is not clear if flaxseed works for reducing symptoms of menopause such as hot flashes. Some research has found that it might modestly reduce symptoms. However, other studies show that it does not work any better than taking a sugar pill placebo. The difference in effectiveness might be due to the dose of flaxseed used.
- Metabolic syndrome (a condition that increases risk for diabetes and heart disease). Evidence on the use of flaxseed for metabolic syndrome is inconsistent. Early research shows that taking flaxseed extract reduces the risk of metabolic syndrome. However, other research shows that taking flaxseed does not improve markers of metabolic syndrome in people also following lifestyle modifications compared to those who just follow lifestyle modifications.
- Prostate cancer. Early research suggests that taking flaxseed and following a low-fat diet can lower prostate-specific antigen (PSA), a marker for prostate cancer, in men who have a precancerous prostate condition. However, in men who have prostate cancer, adding flaxseed to the diet does not lower PSA, but it does seem to lower levels of the hormone testosterone and slow the rate at which cancer cells multiply.
- Weight loss. Research in young adults who are not obese suggests that taking flaxseed fiber before a meal might reduce appetite and food intake. However, other research suggests that taking 40 grams of flaxseed daily for 12 weeks does not reduce body weight or mass in obese adults.
- Stomach upset.
- Bladder inflammation.
- Skin irritation.
- Attention deficit-hyperactivity disorder (ADHD) .
- Other conditions.
More evidence is needed to rate of flaxseed for these uses.
Flaxseed is a good source of dietary fiber and omega-3 fatty acids. The fiber in flaxseed is found primarily in the seed coat. Taken before a meal, flaxseed fiber seems to make people feel less hungry, so that they might eat less food. Researchers believe this fiber binds with cholesterol in the intestine and prevents it from being absorbed. Flaxseed also seems to make platelets, the blood cells involved in clotting, less sticky. Overall, flaxseed’s effects on cholesterol and blood clotting may lower the risk of “hardening of the arteries” (atherosclerosis).
Flaxseed is sometimes tried for cancer because it is broken down by the body into chemicals called “lignans.” Lignans are similar to the female hormone estrogen - so similar, in fact, that they compete with estrogen for a part in certain chemical reactions. As a result, natural estrogens seem to become less powerful in the body. Some researchers believe that lignans may be able to slow down the progress of certain breast cancers and other types of cancers that need estrogen to thrive.
For systemic lupus erythematosus (SLE), flaxseed is thought to improve kidney function by decreasing the thickness of blood, reducing cholesterol levels, and reducing swelling.
Flaxseed is LIKELY SAFE for most adults when taken by mouth. Adding flaxseed to the diet might increase the number of bowel movements each day. It might also cause gastrointestinal (GI) side effects such as bloating, gas, abdominal pain, constipation, diarrhea, stomachache, and nausea. Higher doses are likely to cause more GI side effects.
There is some concern that taking large amounts of flaxseed could block the intestines due to the bulk-forming laxative effects of flaxseed. Flaxseed should be taken with plenty of water to prevent this from happening.
Taking flaxseed extracts that contain lignans in concentrated form is POSSIBLY SAFE. Lignans are the chemicals in flaxseed that are thought to be responsible for many of the effects. Some clinical research shows that a specific flaxseed lignan extract (Flax Essence, Jarrow Formulas) can be safely used for up to 12 weeks.
Products that contain partially defatted flaxseed, which is flaxseed with less alpha-linolenic acid content, are available. Some men choose these products because they have heard that alpha-linolenic acid might raise their risk of getting prostate cancer. It’s important to remember that the source of the alpha-linolenic acid is key. Alpha-linolenic acid from dairy and meat sources has been positively associated with prostate cancer. However, alpha-linolenic acid from plant sources, such as flaxseed, does not seem to affect prostate cancer risk. Men should not worry about getting alpha-linoleic acid from flaxseed. On the other hand, there is a concern that partially defatted flaxseed might raise triglyceride levels too much. Triglycerides are a type of blood fat.
Raw or unripe flaxseed is POSSIBLY UNSAFE. Flaxseed in these forms is thought to be poisonous.
Special precautions & warnings:
Pregnancy and breast-feeding: Taking flaxseed by mouth during pregnancy is POSSIBLY UNSAFE. Flaxseed can act like the hormone estrogen. Some healthcare providers worry that this might harm the pregnancy, although to date there is no reliable clinical evidence about the effects of flaxseed on pregnancy outcomes. The effect of flaxseed on breast-fed infants is unknown at this time. Stay on the safe side, and don’t use flaxseed if you are pregnant or breast-feeding.
Bleeding disorders: Flaxseed might slow clotting. This raises the concern that it could increase the risk of bleeding in people with bleeding disorders. Don’t use it, if you have a bleeding disorder.
Diabetes: There is some evidence that flaxseed can lower blood sugar levels and might increase the blood sugar-lowering effects of some medicines used for diabetes. There is a concern that blood sugar could drop too low. If you have diabetes and use flaxseed, monitor your blood sugar levels closely.
Gastrointestinal (GI) obstruction: People with a bowel obstruction, a narrowed esophagus (the tube between the throat and the stomach), or an inflamed (swollen) intestine should avoid flaxseed. The high fiber content of flaxseed might make the obstruction worse.
Hormone-sensitive cancers or conditions: Because flaxseed might act somewhat like the hormone estrogen, there is some concern that flaxseed might make hormone-sensitive conditions worse. Some of these conditions include breast, uterine, and ovarian cancer; endometriosis; and uterine fibroids. However, some early laboratory and animal research suggests that flaxseed might actually oppose estrogen and might be protective against hormone-dependent cancer. Still, until more is known, avoid excessive use of flaxseed if you have a hormone-sensitive condition.
High triglyceride levels (hypertriglyceridemia): Partially defatted flaxseed (flaxseed with less alpha linolenic acid content) might increase triglyceride levels. If your triglyceride levels are too high, don’t take flaxseed.
Low blood pressure (hypotension): Flaxseeds might lower diastolic blood pressure. Theoretically, taking flaxseeds might cause blood pressure to become too low in individuals with low blood pressure.
High blood pressure (hypertension): Flaxseeds might lower diastolic blood pressure. Theoretically, taking flaxseeds might cause blood pressure to become too low in individuals with high blood pressure who are taking blood pressure-lowering medication.
Be cautious with this combination.
There is some evidence that flaxseed might interfere with the body's ability to take in and use acetaminophen. It's not known, though, whether this interaction is important.
Bacteria in the intestine convert some of the chemicals in flaxseed into lignans, which are thought to be responsible for many of the possible benefits of flaxseed. However, because antibiotics kill these bacteria, lignans might not be formed as usual. This might alter the effects of flaxseed.
Flaxseed can act like the female hormone estrogen. It can compete with estrogens that are included in birth control pills and hormone replacement treatments. Healthcare providers are concerned that flaxseed might make these estrogen-containing drugs less effective.
There is some evidence that flaxseed might interfere with the body's ability to take in and use furosemide. It's not known, though, whether this interaction is important.
Ketoprofen (Orudis, Oruvail)
There is some evidence that flaxseed might interfere with the body's ability to take in and use ketoprofen. It's not known, though, whether this interaction is important.
Medications for diabetes (Antidiabetes drugs)
Some evidence suggests that flaxseed can lower blood sugar levels. Diabetes medications are also used to lower blood sugar. Taking flaxseed along with diabetes medications might cause your blood sugar to become too low. Monitor your blood sugar closely. The dose of your diabetes medication might need to be changed.
Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, metformin (Glucophage), pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.
Medications taken by mouth (Oral drugs)
Flaxseed can act like a laxative. There is some concern that it might interfere with the body's ability to absorb medications taken by mouth because it might sweep them out of the digestive tract too quickly. To avoid this problem, take medications an hour before or two hours after taking flaxseed.
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs)
Flaxseed might slow blood clotting. Taking flaxseed along with medications that also slow clotting might increase the chances of bruising and bleeding.
Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), and others.
There is some evidence that flaxseed might interfere with the body's ability to take in and use metoprolol. It's not known, though, if this interaction is important.
Herbs and supplements that can lower blood sugar
Flaxseed might lower blood sugar. If it is taken along with other herbs and supplements that might lower blood sugar, blood sugar might become too low in some people. Some herbs and supplements that might lower blood sugar include alpha-lipoic acid, bitter melon, chromium, devil's claw, fenugreek, garlic, guar gum, horse chestnut, Panax ginseng, psyllium, Siberian ginseng, and others.
Herbs and supplements that lower blood pressure (hypotensive herbs and supplements)
Flaxseed might lower blood pressure. It has the potential to have additive effects with other herbs and supplements that also lower blood pressure, and blood pressure may become too low. Other herbs and supplements that can lower blood pressure include andrographis, casein peptides, cat's claw, coenzyme Q-10, fish oil, L-arginine, lyceum, stinging nettle, theanine, and others.
Herbs and supplements that might slow blood clotting
Flaxseed can increase the amount of time it takes for blood to clot. Taking flaxseed along with other herbs and supplements that slow blood clotting might increase the risk of bleeding and bruising in some people. Some of these herbs include angelica, clove, danshen, garlic, ginger, ginkgo, Panax ginseng, and others.
There are no known interactions with foods.
The following doses have been studied in scientific research:
- For type 2 diabetes: 600 mg of a specific flaxseed lignan extract (Flax Essence, Jarrow Formulas) three times daily, providing 320 mg lignans, for 12 weeks.
- For high cholesterol: Baked goods such as muffins or bread containing flaxseed and ground flaxseed to provide a daily dose of 40-50 grams of flaxseed.
- For improving kidney function in people with systemic lupus erythematosus (SLE): 15 grams of ground flaxseed twice daily with cereal, or tomato or orange juice.
- For improving mild menopausal symptoms: 40 grams of crushed flaxseed or flaxseed in bread daily.
Alasi, Aliviraaii, Brown Flaxseed, Brown-Seeded Flax, Common Flax, Echter Lein, Flachs, Flachssamen, Flax, Flax Hull, Flax Lignans, Flax Meal, Flax Seed, Gemeiner Flachs, Golden Flax, Graine de Lin, Kattan, Keten, Leinsamen, Lignanes de Lin, Lignans, Lin, Lin Commun, Lin Oléagineux, Lin Textile, Linaza, Lini Semen, Linho, Lino, Lino Comune, Lino Mazzese, Lino Usuale, Linseed, Linseed Flax, Lint Bells, Linum, Linum crepitans, Linum humile, Linum usitatissimum, Malsag, Phytoestrogen, Phyto-œstrogène, Saatlein, Ta Ma, Tisii, Winterlien.
To learn more about how this article was written, please see the Natural Medicines Comprehensive Database methodology.methodology (//www.nlm.nih.gov/medlineplus/druginfo/natural/methodology.html).
To see all references for the Flaxseed page, please go to http://www.nlm.nih.gov/medlineplus/druginfo/natural/991.html.
- Taylor, C. G., Noto, A. D., Stringer, D. M., Froese, S., and Malcolmson, L. Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 2010;29:72-80. View abstract.
- Bloedon, L. T., Balikai, S., Chittams, J., Cunnane, S. C., Berlin, J. A., Rader, D. J., and Szapary, P. O. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 2008;27:65-74. View abstract.
- Mandasescu S, Mocanu V, Dascalita AM, et al. Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 2005;109:502-6. View abstract.
- Coulman KD, Liu Z, Michaelides J, et al. Fatty acids and lignans in unground whole flaxseed and sesame seed are bioavailable but have minimal antioxidant and lipid-lowering effects in postmenopausal women. Mol Nutr Food Res 2009;53:1366-75. View abstract.
- Patade A, Devareddy L, Lucas EA, et al. Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women. J Womens Health (Larchmt) 2008;17:355-66. View abstract.
- Pan A, Yu D, Demark-Wahnefried W, et al. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 2009;90:288-97. View abstract.
- Simbalista RL, Sauerbronn AV, Aldrighi JM, Areas JA. Consumption of a flaxseed-rich food is not more effective than a placebo in alleviating the climacteric symptoms of postmenopausal women. J Nutr 2010;140:293-7. View abstract.
- Colli MC, Bracht A, Soares AA, et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. J Med Food 2012;15:840-5. View abstract.
- Wu H, Pan A, Yu Z, et al. Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr 2010;140:1937-42. View abstract.
- Cockerell KM, Watkins AS, Reeves LB, et al. Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial. J Hum Nutr Diet 2012;25:435-43. View abstract.
Cornish SM, Chilibeck PD, Paus-Jennsen L, et al. A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults. Appl Physiol Nutr Metab 2009;34:89-98. View abstract.
- Rhee Y, Brunt A. Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design. Nutr J 2011;10:44. View abstract.
- Mani UV, Mani I, Biswas M, Kumar SN. An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus. J Diet Suppl 2011;8:257-65. View abstract.
- Zhang W, Wang X, Liu Y, et al. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia. J Med Food 2008;11:207-14. View abstract.
- Sairanen U, Piirainen L, Nevala R, Korpela R. Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects. Eur J Clin Nutr 2007;61:1423-8. View abstract.
- Faizi S, Siddiqui BS, Saleem R, et al. Hypotensive constituents from the pod of Moringa oleifera. Planta Med 1998;64:225-8. View abstract.
- Pruthi S, Qin R, Terstreip SA, et al. A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause 2012;19:48-53. View abstract.
- Ibrügger S, Kristensen M, Mikkelsen MS, Astrup A. Flaxseed dietary fiber supplements for suppression of appetite and food intake. Appetite 2012;58:490-5. View abstract.
- Kuijsten A, Arts IC, Hollman PC, et al. Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2006;15:1132-6. View abstract.
- Milder IE, Feskens EJ, Arts IC, et al. Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen Elderly Study. Am J Clin Nutr 2006;84:400-5. View abstract.
- Zeleniuch-Jacquotte A, Lundin E, Micheli A, et al. Circulating enterolactone and risk of endometrial cancer. Int J Cancer 2006;119:2376-81. View abstract.
- Thanos J, Cotterchio M, Boucher BA, et al. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006;17:1253-61. View abstract.
- Cotterchio M, Boucher BA, Manno M, et al. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 2006;136:3046-53. View abstract.
- Fink BN, Steck SE, Wolff MS, et al. Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 2007;165:514-23. View abstract.
- Verheus M, van Gils CH, Keinan-Boker L, et al. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 2007;25:648-55. View abstract.
- Touillaud MS, Thiebaut AC, Fournier A, et al. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 2007;99:475-86. View abstract.
- Heald CL, Ritchie MR, Bolton-Smith C, et al. Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 2007;98:388-96. View abstract.
- Cotterchio M, Boucher BA, Kreiger N, et al. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada). Cancer Causes Control 2008;19:259-72. View abstract.
- Kuijsten A, Hollman PC, Boshuizen HC, et al. Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study. Am J Epidemiol 2008;167:734-42. View abstract.
- Suzuki R, Rylander-Rudqvist T, Saji S, et al. Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. Br J Cancer 2008;98:636-40. View abstract.
- Hedelin M, Lof M, Olsson M, et al. Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 2008;138:938-45. View abstract.
- Sonestedt E, Borgquist S, Ericson U, et al. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:3241-51. View abstract.
- Chen J, Power KA, Mann J, et al. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med (Maywood) 2007;232:1071-80. View abstract.
- Chen J, Power KA, Mann J, et al. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. Nutr Cancer 2007;58:162-70. View abstract.
- Saarinen NM, Power K, Chen J, Thompson LU. Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int J Cancer 2006;119:925-31. View abstract.
- Chen J, Wang L, Thompson LU. Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett 2006;234:168-75. View abstract.
- Wang L, Chen J, Thompson LU. The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenografts is attributed to both its lignan and oil components. Int J Cancer 2005;116:793-8. View abstract.
- Chen J, Hui E, Ip T, Thompson LU. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin Cancer Res 2004;10:7703-11. View abstract.
- Pan A, Sun J, Chen Y, et al. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2007;2:e1148. View abstract.
- Pan A, Demark-Wahnefried W, Ye X, et al. Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. Br J Nutr 2008;101:1145-9. View abstract.
- Goss PE, Li T, Theriault M, et al. Effects of dietary flaxseed in women with cyclical mastalgia. Breast Cancer Res Treat 2000;64:49
- Thompson LU, Chen JM, Li T, et al. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 2005;11:3828-35. View abstract.
- Laitinen LA, Tammela PS, Galkin A, et al. Effects of extracts of commonly consumed food supplements and food fractions on the permeability of drugs across Caco-2 cell monolayers. Pharm Res 2004;21:1904-16. View abstract.
- Khan G, Penttinen P, Cabanes A, et al. Maternal flaxseed diet during pregnancy or lactation increases female rat offspring's susceptibility to carcinogen-induced mammary tumorigenesis. Reprod Toxicol 2007;23:397-406. View abstract.
- Lewis JE, Nickell LA, Thompson LU, et al. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause 2006;13:631-42. View abstract.
- Demark-Wahnefried W, Polascik TJ, George SL, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 2008;17:3577-87. View abstract.
- Demark-Wahnefried W, Price DT, Polascik TJ, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 2001;58:47-52. View abstract.
- Chavarro JE, Stampfer MJ, Li H, et al. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1364-70. View abstract.
- Freese R, Mutanen M. Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. Am J Clin Nutr 1997;66:591-8. View abstract.
- Schabath MB, Hernandez LM, Wu X, et al. Dietary phytoestrogens and lung cancer risk. JAMA 2005;294:1493-1504. View abstract.
- Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004;134:919-22. View abstract.
- Leitzmann MF, Stampfer MJ, Michaud DS, et al. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 2004;80:204-16. View abstract.
- Finnegan YE, Minihane AM, Leigh-Firbank EC, et al. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 2003;77:783-95. View abstract.
- Leon F, Rodriguez M, Cuevas M. Anaphylaxis to Linum. Allergol Immunopathol (Madr) 2003;31:47-9. . View abstract.
- Dodin S, Lemay A, Jacques H, et al. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005;90:1390-7. View abstract.
- Laaksonen DE, Laukkanen JA, Niskanen L, et al. Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort study. Int J Cancer 2004;111:444-50.. View abstract.
- Demark-Wahnefried W, Robertson CN, Walther PJ, et al. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 2004;63:900-4.. View abstract.
- Brooks JD, Ward WE, Lewis JE, et al. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 2004;79:318-25.. View abstract.
- Bloedon LT, Szapary PO. Flaxseed and cardiovascular risk. Nutr Rev 2004;62:18-27. View abstract.
- Lemay A, Dodin S, Kadri N, et al. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 2002;100:495-504.. View abstract.
- Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002;87:1527-32.. View abstract.
- Rose DP. Dietary fiber and breast cancer. Nutr Cancer 1990;13:1-8.. View abstract.
- Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986;25:791-7.. View abstract.
- Wang C, Makela T, Hase T, et al. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 1994;50:205-12.. View abstract.
- Mousavi Y, Adlercreutz H. Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 1992;41:615-9.. View abstract.
- Serraino M, Thompson LU. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 1992;17:153-9. View abstract.
- Arjmandi BH. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. J Am Coll Nutr 2001;20:398S-402S. View abstract.
- Kilkkinen A, Stumpf K, Pietinen P, et al. Determinants of serum enterolactone concentration. Am J Clin Nutr 2001;73:1094-100. View abstract.
- Adlercreutz H, Heikkinen R, Woods M, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982;2:1295-9. View abstract.
- Adlercreutz H. Diet, breast cancer, and sex hormone metabolism. Ann N Y Acad Sci 1990;595:281-90. View abstract.
- Rickard SE, Yuan YV, Thompson LU. Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 2000;161:47-55. View abstract.
- Serraino M, Thompson LU. The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett 1991;60:135-42. View abstract.
- Clark WF, Kortas C, Heidenheim P, et al. Flaxseed in lupus nephritis: a two-year nonplacebo-controlled crossover study. J Am Coll Nutr 2001;20:143-8. View abstract.
- Haggans CJ, Travelli EJ, Thomas W, et al. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9:719-25. View abstract.
- Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993;85:1571-9. View abstract.
- de Deckere EAM, Korver O, Verschuren PM, Katan MB. Health aspects of fish and n-3 polyunsaturated fatty acids from plant and marine origin. Eur J Clin Nutr 1998;52:749-53. View abstract.
- De Stefani E, Deneo-Pellegrini H, Boffetta P, et al. Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 2000;9:335-8. View abstract.
- Crawford M, Galli C, Visioli F, et al. Role of Plant-Derived Omega-3 Fatty Acids in Human Nutrition. Ann Nutr Metab 2000;44:263-5. View abstract.
- Alonso L, Marcos ML, Blanco JG, et al. Anaphylaxis caused by linseed (flaxseed) intake. J Allergy Clin Immunol 1996;98:469-70. View abstract.
- Jenkins DJ, Kendall CWC, Vidgen E, et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled, crossover trial. Am J Clin Nutr 1999;69:395-402. View abstract.
- Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998;136:367-75. View abstract.
- Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 1997;132:69-76. View abstract.
- Thompson LU, Rickard SE, Orcheson LJ, Seidl MM. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 1996;17:1373-6. View abstract.
- Cunnane SC, Hamadeh MJ, Liede AC, et al. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995;61:62-8. View abstract.
- Clark WF, Parbtani A, Huff MW, et al. Flaxseed: a potential treatment for lupus nephritis. Kidney Int 1995;48:475-80. View abstract.
- Lampe JW, Martini MC, Kurzer MS, et al. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 1994;60:122-8. View abstract.
- Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in hyperlipemic humans with flaxseed supplementation: a preliminary report. J Am Coll Nutr 1993;12:501-4. View abstract.
- Cunnane SC, Ganguli S, Menard C, et al. High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 1993;69:443-53. View abstract.
- Nordstrom DC, Honkanen VE, Nasu Y, et al. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed. Rheumatol Int 1995;14:231-4. View abstract.
- Thompson LU, Rickard SE, Cheung F, et al. Variability in anticancer lignan levels in flaxseed. Nutr Cancer 1997;27:26-30. View abstract.
- Sung MK, Lautens M, Thompson LU. Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Res 1998;18:1405-8. View abstract.
- Nesbitt PD, Lam Y, Thompson LU. Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 1999;69:549-55. View abstract.
- Haggans CJ, Hutchins AM, Olson BA, et al. Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr Cancer 1999;33:188-95. View abstract.
- Ramon JM, Bou R, Romea S, et al. Dietary fat intake and prostate cancer risk: a case-control study in Spain. Cancer Causes Control 2000;11:679-85. View abstract.
- Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: current status. J Natl Cancer Inst 1999;91:414-28. View abstract.
- Show more references
- Show fewer references
Last reviewed - 02/14/2015
This copyrighted, evidence-based medicine resource is provided by Natural Medicines Comprehensive Database Consumer Version. Natural Medicines Comprehensive Database disclaims any responsibility related to consequences of using any product. This monograph should not replace advice from a healthcare professional and should not be used for the diagnosis or treatment of any medical condition.
Copyright © 1995 - 2015 Therapeutic Research Center, publishers of Natural Medicines, Prescriber's Letter, Pharmacist's Letter. All rights reserved. For scientific data on natural medicines, professionals may consult Natural Medicines